Celcuity Inc. Profile Avatar - Palmy Investing

Celcuity Inc.

Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the …

Biotechnology
US, Minneapolis [HQ]
Financials

Analysts

Reported
Past Estimate Consensus
Future Estimate Consensus
Celcuity Inc. can't present any analysts estimates at the moment detail analysis.
End of CELC's Analysis
CIK: 1603454 CUSIP: 15102K100 ISIN: US15102K1007 LEI: - UEI: -
Secondary Listings
CELC has no secondary listings inside our databases.